A cancer charity sunsets its liquor gala; the courts are less consistent

The American Cancer Society has cancelled its Wine and Spirits Industry's Gala, an October event at Manhattan's Rainbow Room that had raised money from members of the alcohol industry for decades, a spokesperson confirmed to STAT ^[1][2]. It landed less than two months after STAT's Isabella Cueto and Lev Facher reported that the charity had for years taken at least $22 million from wine and liquor executives ^[4][6], which makes this an unusually datable case of a disclosure moving an institution rather than merely embarrassing it.

The wording matters. Spokesperson Michele Money-Carson said ACS "decided to sunset the Wine & Spirits Industry Gala, and the October event will not take place," and framed the move as part of an ongoing evaluation of how the group's events and fundraising align with its mission and prevention guidance ^[3][8]. The quoted statement does not mention the reporting ^[17]. So the causal claim rests on the calendar, not on an admission: the confirmation came roughly six to ten weeks before an event that had run for decades ^[15].

Note also what the number is. The $22 million figure is a floor across multiple years ^[4], not an annual run rate, so the size of the revenue hole ACS just accepted cannot be computed from what is public. Some critics, including a former cancer society executive, had called the gala an unsettling conflict of interest and inappropriate given alcohol's known links to cancer ^[5]. Public health professor Michael Siegel put it more bluntly to STAT: "Can you imagine the American Cancer Society hosting a tobacco industry gala? This is basically the same thing," calling the cancellation a wise decision ^[9].

The same STAT newsletter carried a second governance item pointing the other way ^[16]. Last week a federal appeals court ruled in favour of the Justice Department's effort to obtain gender-affirming care patient records from the telehealth company QueerDoc, with two of three panel judges finding nothing out of line about the request ^[10]. Most judges to date have treated such requests as overreaching or brought for an improper purpose ^[11], and QueerDoc was the first of many quashed requests that federal law enforcement chose to appeal ^[12]. Some legal experts think the case is a candidate for en banc review by the full court ^[18].

Meanwhile the DOJ has changed its approach. Since oral arguments in March it has concentrated its subpoena efforts in a Texas district court with a strong conservative reputation ^[13], while at least one later criminal subpoena, for records from NYU, has been temporarily blocked by a New York federal court ^[14].

The two stories share a mechanic and invert it. Exposure of an institution's funding sources produced a fast retreat; exposure of individual patients' records is still being litigated venue by venue, with the outcome depending on which panel hears it.

Watch whether QueerDoc's counsel seeks en banc review ^[18], whether the Texas venue strategy yields rulings that split further from the New York block ^[13][14], and whether ACS says anything about replacing the gala's revenue or the money already banked ^[4].